搜索临床试验以:capecitabine camrelizumab apatinib
总计4197个结果
-
Xiangya Hospital of Central South UniversitySuzhou Suncadia Biopharmaceuticals Co., Ltd.招聘中
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人根治性切除或消融后复发风险高的肝细胞癌 (HCC) 患者的辅助治疗中国
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.招聘中
-
Sun Yat-sen University主动,不招人
-
The First Affiliated Hospital of Zhengzhou University招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Sun Yat-sen University招聘中
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Tragara Pharmaceuticals, Inc.终止
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Hunan Cancer HospitalJiangsu Hengrui Pharmaceuticals Co.,Ltd招聘中
-
Zhejiang UniversityHuashan Hospital; West China Hospital; The First Affiliated Hospital of Zhengzhou University; The... 和其他合作者未知
-
Guangxi Medical UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Ruijin Hospital招聘中Hepatobiliary, Pancreatic and Other Gastrointestinal Carcinoma (Non-stomach, Non-esophagi)中国
-
Peking Union Medical College Hospital招聘中
-
Zhejiang Cancer Hospital尚未招聘胃癌、HIPEC、抗 PD-1 抗体 Camrelizumab (SHR-1210)、化疗和手术中国
-
Memorial Sloan Kettering Cancer CenterPfizer; National Comprehensive Cancer Network完全的